Ultragenyx Pharmaceutical Inc. (RARE)
USD 32.41
(-7.76%)
USD 32.41
(-7.76%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -170.41 Million USD | -68.14% |
| 2022 | -101.35 Million USD | 61.84% |
| 2021 | -265.61 Million USD | 60.08% |
| 2020 | -665.29 Million USD | -67.75% |
| 2019 | -396.59 Million USD | -249.63% |
| 2018 | -113.43 Million USD | -12.88% |
| 2017 | -100.48 Million USD | 37.63% |
| 2016 | -161.12 Million USD | -72.19% |
| 2015 | -93.56 Million USD | -284.68% |
| 2014 | -24.32 Million USD | -227.51% |
| 2013 | -7.42 Million USD | 91.38% |
| 2012 | -86.19 Million USD | -709.68% |
| 2011 | -10.64 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 439.67 Million USD | -45.96% |
| 2024 Q1 | 813.62 Million USD | 577.43% |
| 2023 Q2 | -76.33 Million USD | -33.52% |
| 2023 Q1 | -57.16 Million USD | 43.6% |
| 2023 FY | -170.41 Million USD | -68.14% |
| 2023 Q4 | -170.41 Million USD | -181.64% |
| 2023 Q3 | -60.5 Million USD | 20.73% |
| 2022 Q2 | -122.33 Million USD | -6.73% |
| 2022 Q3 | -356.96 Million USD | -191.79% |
| 2022 FY | -101.35 Million USD | 61.84% |
| 2022 Q4 | -101.35 Million USD | 71.61% |
| 2022 Q1 | -114.62 Million USD | 56.85% |
| 2021 Q4 | -265.61 Million USD | -73.04% |
| 2021 Q3 | -153.49 Million USD | 37.27% |
| 2021 Q2 | -244.7 Million USD | 27.53% |
| 2021 FY | -265.61 Million USD | 60.08% |
| 2021 Q1 | -337.66 Million USD | 49.25% |
| 2020 Q1 | -255.74 Million USD | 35.51% |
| 2020 Q4 | -665.29 Million USD | -334.74% |
| 2020 Q3 | -153.03 Million USD | 47.6% |
| 2020 Q2 | -292.07 Million USD | -14.2% |
| 2020 FY | -665.29 Million USD | -67.75% |
| 2019 Q2 | -91.37 Million USD | 62.16% |
| 2019 FY | -396.59 Million USD | -249.63% |
| 2019 Q1 | -241.46 Million USD | -112.88% |
| 2019 Q3 | -84.08 Million USD | 7.98% |
| 2019 Q4 | -396.59 Million USD | -371.68% |
| 2018 Q1 | -226.73 Million USD | -125.63% |
| 2018 Q4 | -113.43 Million USD | -36.74% |
| 2018 FY | -113.43 Million USD | -12.88% |
| 2018 Q3 | -82.95 Million USD | 25.17% |
| 2018 Q2 | -110.85 Million USD | 51.11% |
| 2017 FY | -100.48 Million USD | 37.63% |
| 2017 Q2 | -90.75 Million USD | 43.1% |
| 2017 Q3 | -60.4 Million USD | 33.44% |
| 2017 Q1 | -159.5 Million USD | 1.0% |
| 2017 Q4 | -100.48 Million USD | -66.35% |
| 2016 Q1 | -70.76 Million USD | 24.37% |
| 2016 FY | -161.12 Million USD | -72.19% |
| 2016 Q2 | -55.06 Million USD | 22.18% |
| 2016 Q4 | -161.12 Million USD | -13.24% |
| 2016 Q3 | -142.28 Million USD | -158.37% |
| 2015 FY | -93.56 Million USD | -284.68% |
| 2015 Q4 | -93.56 Million USD | 43.87% |
| 2015 Q3 | -166.68 Million USD | -218.4% |
| 2015 Q2 | -52.35 Million USD | 70.6% |
| 2015 Q1 | -178.04 Million USD | -631.95% |
| 2014 Q1 | -55.44 Million USD | -646.56% |
| 2014 FY | -24.32 Million USD | -227.51% |
| 2014 Q4 | -24.32 Million USD | 54.44% |
| 2014 Q3 | -53.38 Million USD | -205.91% |
| 2014 Q2 | -17.45 Million USD | 68.52% |
| 2013 Q3 | -6.04 Million USD | 0.0% |
| 2013 FY | -7.42 Million USD | 91.38% |
| 2013 Q1 | 86.19 Million USD | 200.0% |
| 2013 Q4 | -7.42 Million USD | -22.78% |
| 2012 Q4 | -86.19 Million USD | 0.0% |
| 2012 FY | -86.19 Million USD | -709.68% |
| 2011 FY | -10.64 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -204.639% |
| Alkermes plc | -166.73 Million USD | -2.205% |
| Agenus Inc. | 274.13 Million USD | 162.164% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 109.113% |
| Aptorum Group Limited | 1.35 Million USD | 12657.791% |
| Ardelyx, Inc. | 34.51 Million USD | 593.785% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 4081.659% |
| Bicycle Therapeutics plc | -481.46 Million USD | 64.605% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 571.241% |
| ChromaDex Corporation | -24.04 Million USD | -608.645% |
| Chimerix, Inc. | -25.51 Million USD | -567.849% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 2545.654% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -619.749% |
| CRISPR Therapeutics AG | -150.84 Million USD | -12.974% |
| Precision BioSciences, Inc. | -85.41 Million USD | -99.526% |
| Dyadic International, Inc. | -6.37 Million USD | -2571.878% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -969.573% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2323.288% |
| Lantern Pharma Inc. | -21.7 Million USD | -685.204% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -54.17% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1894.75% |
| Incyte Corporation | -3.17 Billion USD | 94.633% |
| IO Biotech, Inc. | -140.69 Million USD | -21.12% |
| Jaguar Health, Inc. | 29.39 Million USD | 679.82% |
| Novavax, Inc. | -298.29 Million USD | 42.87% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 3293.086% |
| Opthea Limited | 28.15 Million USD | 705.222% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -915.04% |
| ContextLogic Inc. | -232 Million USD | 26.545% |
| MiMedx Group, Inc. | -33.9 Million USD | -402.684% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1771.555% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -7254.899% |
| NextCure, Inc. | -6.47 Million USD | -2531.079% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -237.449% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -2571.5% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1501.063% |
| Vaxcyte, Inc. | -368.22 Million USD | 53.72% |
| PDS Biotechnology Corporation | -32.7 Million USD | -421.005% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1086.312% |
| Pharming Group N.V. | 109.8 Million USD | 255.199% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -879.622% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 2.748% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -820.175% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -820.175% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2300.211% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2808.106% |
| Acelyrin, Inc. | -216.9 Million USD | 21.433% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2937.556% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -9784.861% |
| Summit Therapeutics Inc. | 34.67 Million USD | 591.478% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -2404.998% |
| Senti Biosciences, Inc. | 1.74 Million USD | 9893.966% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 7.688% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -120.029% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2711.201% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 170909.57% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 27236.146% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -45.597% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -1.297% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 253.707% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2143.483% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -31.988% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2571.718% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 29.686% |
| Immix Biopharma, Inc. | -17.5 Million USD | -873.255% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 46.191% |
| MEI Pharma, Inc. | -3.7 Million USD | -4499.595% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1462.121% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 205.362% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 713.158% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2323.288% |
| Precigen, Inc. | -481 Thousand USD | -35329.314% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1310.248% |
| AlloVir, Inc. | -62.69 Million USD | -171.829% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -206.425% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 376.352% |
| ImmuCell Corporation | 10.99 Million USD | 1650.558% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -10.554% |
| Onconetix, Inc. | 5.33 Million USD | 3296.418% |
| PureTech Health plc | -167.19 Million USD | -1.925% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -459.471% |
| Elevation Oncology, Inc. | -19.11 Million USD | -791.385% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -3371.481% |
| Seer, Inc. | -4.24 Million USD | -3919.222% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -608.97% |
| Innoviva, Inc. | 255.56 Million USD | 166.682% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -205.053% |
| ESSA Pharma Inc. | -33.62 Million USD | -406.862% |
| GlycoMimetics, Inc. | -40.98 Million USD | -315.804% |
| GT Biopharma, Inc. | -1.02 Million USD | -16590.989% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -151.413% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 378.197% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -27.1% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1129.9% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -490.243% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -226112.6% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -452.184% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1979.536% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -5346.277% |
| Soligenix, Inc. | -4.95 Million USD | -3341.617% |
| Century Therapeutics, Inc. | 847 Thousand USD | 20219.835% |
| Kura Oncology, Inc. | -20.11 Million USD | -747.077% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -316.398% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1929.233% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 9454.749% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -5230.466% |
| Autolus Therapeutics plc | -186.59 Million USD | 8.673% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -245.641% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 38.209% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 597.301% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 203.679% |
| GRI Bio, Inc. | -1.79 Million USD | -9399.164% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1797.074% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -412.418% |
| IGM Biosciences, Inc. | -72.6 Million USD | -134.712% |
| INmune Bio, Inc. | -25.41 Million USD | -570.635% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 212.894% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -236.396% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -948.748% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -5807.084% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 548.284% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -313.779% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 634.468% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 145.089% |
| Verastem, Inc. | -37.27 Million USD | -357.146% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1778.265% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -228.593% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1025.966% |
| Histogen Inc. | -7.48 Million USD | -2176.145% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -688.709% |
| Surrozen, Inc. | -32.66 Million USD | -421.721% |
| Organovo Holdings, Inc. | -1.5 Million USD | -11208.228% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3954.133% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 998.803% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 6614.335% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 4200.457% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1933.313% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -292.282% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1069.079% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 46.206% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -23501.224% |
| Apollomics, Inc. | -27.39 Million USD | -522.066% |
| Amarin Corporation plc | -191.04 Million USD | 10.796% |
| Mesoblast Limited | 55.96 Million USD | 404.514% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1068.507% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -573.79% |
| Synaptogenix, Inc. | -28.66 Million USD | -494.578% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -18106.731% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 449.698% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -19667.681% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2245.35% |
| Exelixis, Inc. | -73.05 Million USD | -133.285% |
| Better Therapeutics, Inc. | -860 Thousand USD | -19715.698% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -609.678% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 29.397% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 23252.136% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2191.099% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 13689.713% |
| Gritstone bio, Inc. | 39.49 Million USD | 531.54% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -102.631% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -6374.39% |
| Avid Bioservices, Inc. | 169.72 Million USD | 200.405% |
| Insmed Incorporated | 721.62 Million USD | 123.616% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1764.188% |
| MediWound Ltd. | -5.32 Million USD | -3102.086% |
| OmniAb, Inc. | 9.2 Million USD | 1951.733% |
| Alector, Inc. | -35.63 Million USD | -378.197% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 298.224% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -3358.097% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1387.22% |
| Zai Lab Limited | -775 Million USD | 78.011% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 150.04% |
| Aura Biosciences, Inc. | -21.52 Million USD | -691.707% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -106.614% |
| Immunic, Inc. | -45.34 Million USD | -275.86% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 11.8% |
| Veracyte, Inc. | -203.82 Million USD | 16.391% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 126.699% |
| FibroGen, Inc. | 56.76 Million USD | 400.201% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2013.7% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -5927.947% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -8131.225% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 103.712% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -5000.718% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -2.682% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1054.064% |
| Galecto, Inc. | -21.21 Million USD | -703.238% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -616.481% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 110.859% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -596.367% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1380.968% |
| XBiotech Inc. | -200.02 Million USD | 14.802% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -102.631% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3863.582% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -383.269% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -120.693% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3094.465% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -84.484% |
| Vaxxinity, Inc. | 10.13 Million USD | 1781.948% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 123.146% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1482.672% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -158.377% |
| NexImmune, Inc. | -3.13 Million USD | -5338.239% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -4835.741% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1027.721% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -528.838% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1798.552% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -136697.11% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -320.031% |
| Ainos, Inc. | 4.07 Million USD | 4278.96% |
| Pluri Inc. | 22.82 Million USD | 846.485% |
| Prothena Corporation plc | -608.34 Million USD | 71.987% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -43.5% |
| Celularity Inc. | 65.19 Million USD | 361.413% |
| Rallybio Corporation | -24.1 Million USD | -607.058% |
| Cue Biopharma, Inc. | -33.81 Million USD | -403.903% |
| MeiraGTx Holdings plc | -40.3 Million USD | -322.845% |
| Omeros Corporation | 331.17 Million USD | 151.458% |
| Humacyte, Inc. | -22.48 Million USD | -657.872% |
| Immunocore Holdings plc | -358.59 Million USD | 52.477% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -593.449% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -451.487% |
| Blueprint Medicines Corporation | 702.83 Million USD | 124.247% |
| CalciMedica, Inc. | -5.53 Million USD | -2981.646% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 9.46% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1568.445% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -325.644% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -412.48% |
| Pulmatrix, Inc. | -10.41 Million USD | -1535.932% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2751.18% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -346.791% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -52.973% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -184.29% |
| Cytokinetics, Incorporated | 642.37 Million USD | 126.529% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2826.584% |
| Nutriband Inc. | -251.65 Thousand USD | -67617.171% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -399.472% |
| Vor Biopharma Inc. | 4.3 Million USD | 4063.14% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.177% |
| Evogene Ltd. | -19.63 Million USD | -767.959% |
| ProKidney Corp. | -56.23 Million USD | -203.035% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -250.129% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1744.88% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 112.495% |
| CorMedix Inc. | -43.05 Million USD | -295.831% |
| BioLineRx Ltd. | 7.33 Million USD | 2422.996% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -520.481% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 469.287% |
| Atai Life Sciences N.V. | -28.55 Million USD | -496.733% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 7740.116% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -646.91% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1060.897% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -126.996% |
| MediciNova, Inc. | -50.78 Million USD | -235.571% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -116.249% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -757468.349% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2541.033% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 14.716% |
| Biomea Fusion, Inc. | -166.57 Million USD | -2.308% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 4.783% |
| Mereo BioPharma Group plc | -51.46 Million USD | -231.102% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -79.679% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 41.988% |
| Absci Corporation | -72.59 Million USD | -134.738% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3832.26% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 27.309% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -80.887% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -78.08% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -336.145% |
| Allakos Inc. | -24.97 Million USD | -582.342% |
| Imunon, Inc. | -4.21 Million USD | -3944.162% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1055.983% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -25.86% |
| BioAtla, Inc. | -109.01 Million USD | -56.328% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 23252.136% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -18048.562% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1524.16% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -703.731% |
| XOMA Corporation | -29 Million USD | -487.638% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -929.076% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1790.14% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2187.757% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -36.73% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 18.134% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -108.385% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -83.71% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -19734.517% |
| Akari Therapeutics, Plc | -3.84 Million USD | -4332.12% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10600.712% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 112.341% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -14243.067% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3981.007% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 250.171% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 236912.484% |
| Orgenesis Inc. | 21.78 Million USD | 882.294% |
| Entera Bio Ltd. | -10.62 Million USD | -1503.302% |
| GH Research PLC | -78.07 Million USD | -118.265% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -664.604% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -539.24% |
| Xencor, Inc. | 29.64 Million USD | 674.872% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -8551.333% |
| Replimune Group, Inc. | 1.41 Million USD | 12169.051% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -69483.272% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -34.804% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -14243.067% |
| Portage Biotech Inc. | -4.98 Million USD | -3321.301% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -757468.349% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -157.728% |
| OncoCyte Corporation | -6.56 Million USD | -2496.602% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 19089.585% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -3640.745% |
| Purple Biotech Ltd. | -14.13 Million USD | -1105.369% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -617.356% |
| scPharmaceuticals Inc. | -6.54 Million USD | -2503.743% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -920.928% |
| HilleVax, Inc. | -165.48 Million USD | -2.979% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -6614.539% |
| Tharimmune, Inc. | -10.93 Million USD | -1458.386% |
| Genprex, Inc. | -6.73 Million USD | -2429.302% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 53.793% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -92.646% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -12063.812% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -5037.708% |
| OKYO Pharma Limited | -826.84 Thousand USD | -20510.197% |
| Savara Inc. | 153 Thousand USD | 111482.353% |
| Curis, Inc. | -23.88 Million USD | -613.422% |
| Daré Bioscience, Inc. | -5.15 Million USD | -3203.954% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -21860.356% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2645.087% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 14481.013% |
| BeiGene, Ltd. | -2.25 Billion USD | 92.436% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1481.165% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 71.981% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 8.175% |
| Erasca, Inc. | -37.21 Million USD | -357.908% |
| bluebird bio, Inc. | 108.57 Million USD | 256.962% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -13132.078% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 144.994% |
| DBV Technologies S.A. | -126.98 Million USD | -34.2% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -13132.078% |
| Moderna, Inc. | -2.9 Billion USD | 94.138% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1546.204% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1468.044% |
| Molecular Templates, Inc. | 707 Thousand USD | 24203.96% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -443.225% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 149.166% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -107.666% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -85.779% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -428.058% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -395.738% |
| MacroGenics, Inc. | -66.98 Million USD | -154.408% |
| RenovoRx, Inc. | -1.17 Million USD | -14428.133% |
| Adicet Bio, Inc. | -138.78 Million USD | -22.789% |
| Prime Medicine, Inc. | -27.94 Million USD | -509.91% |
| Aditxt, Inc. | 18.12 Million USD | 1040.434% |
| Adagene Inc. | -87.62 Million USD | -94.477% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3991.176% |
| Quantum-Si incorporated | -118.55 Million USD | -43.741% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 573.309% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2180.047% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -251.306% |
| SciSparc Ltd. | -2.06 Million USD | -8152.542% |
| Vericel Corporation | 1.27 Million USD | 13444.949% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1321.108% |
| Minerva Neurosciences, Inc. | 41 Million USD | 515.603% |
| Generation Bio Co. | 31.44 Million USD | 641.895% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 2.822% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -451.095% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 246.162% |
| Invivyd, Inc. | -198.47 Million USD | 14.138% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -88.784% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -7007.471% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -140.733% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -2396.923% |
| 2seventy bio, Inc. | 181.71 Million USD | 193.781% |
| ADMA Biologics, Inc. | 90.06 Million USD | 289.211% |
| Clene Inc. | 3.34 Million USD | 5202.246% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1776.259% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -692.223% |
| GeoVax Labs, Inc. | -6.45 Million USD | -2541.033% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 50.479% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -555.45% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 195.919% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -4065.03% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 3506.937% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -3171.549% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -30.783% |
| Evaxion Biotech A/S | 5.28 Million USD | 3323.379% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -51.388% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -29.817% |
| Trevena, Inc. | 2.25 Million USD | 7647.166% |
| Surrozen, Inc. | -32.66 Million USD | -421.721% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -230.839% |
| Cingulate Inc. | 3.08 Million USD | 5628.139% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -5702.349% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 2471.156% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1734.15% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -114.837% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -29.64% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -61.467% |
| Clearmind Medicine Inc. | -3.94 Million USD | -4222.361% |
| Kronos Bio, Inc. | -36.05 Million USD | -372.666% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1911.191% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 11787.254% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -214.094% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1282.091% |
| ImmunityBio, Inc. | 618.22 Million USD | 127.565% |
| Korro Bio, Inc. | -132.94 Million USD | -28.187% |
| Kineta, Inc. | -4.54 Million USD | -3652.808% |
| BioVie Inc. | -17.73 Million USD | -861.04% |
| Codexis, Inc. | -43.27 Million USD | -293.832% |
| Celularity Inc. | 65.19 Million USD | 361.413% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -5277.564% |
| Celcuity Inc. | 6.78 Million USD | 2612.195% |
| Virax Biolabs Group Limited | -3.36 Million USD | -4964.423% |
| Cibus, Inc. | -8.07 Million USD | -2009.619% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3929.676% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 3828.993% |
| IN8bio, Inc. | -16.38 Million USD | -939.813% |
| Kodiak Sciences Inc. | -103.87 Million USD | -64.058% |
| Annexon, Inc. | -193.75 Million USD | 12.046% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 473475.0% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -873.856% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -4750.982% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 116.164% |
| Eyenovia, Inc. | 1.25 Million USD | 13638.947% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 733.395% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5154.857% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -412.573% |
| Arcellx, Inc. | -296.95 Million USD | 42.613% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -773.654% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -189.452% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -722.188% |
| Moolec Science SA | 117.61 Thousand USD | 144991.001% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -343.801% |
| Geron Corporation | 14.76 Million USD | 1254.495% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -349.43% |
| Royalty Pharma plc | 5.65 Billion USD | 103.012% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -20.502% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -2338.184% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3077.689% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -21.093% |
| Humacyte, Inc. | -22.48 Million USD | -657.872% |
| Structure Therapeutics Inc. | -124.33 Million USD | -37.057% |
| 89bio, Inc. | -289.05 Million USD | 41.044% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -575.125% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -9457.768% |
| Genelux Corporation | -6.89 Million USD | -2370.141% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -448.682% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 303.848% |
| Notable Labs, Ltd. | -9.77 Million USD | -1643.198% |
| Liquidia Corporation | -80.17 Million USD | -112.551% |
| Mustang Bio, Inc. | -3.73 Million USD | -4461.429% |
| Immunovant, Inc. | -635.22 Million USD | 73.173% |
| Quantum-Si incorporated | -118.55 Million USD | -43.741% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -870.252% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -4013.324% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2223.022% |
| Acasti Pharma Inc. | -23 Million USD | -640.774% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -4960.986% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -948.748% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -23.722% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -5368.396% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -666.53% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -817.739% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -0.672% |
| PepGen Inc. | -60.67 Million USD | -180.888% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -641.709% |
| United Therapeutics Corporation | -507.7 Million USD | 66.434% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -791.012% |
| Solid Biosciences Inc. | -47.75 Million USD | -256.89% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -19667.681% |
| Immuneering Corporation | -54.94 Million USD | -210.168% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3954.133% |
| Silo Pharma, Inc. | -3.52 Million USD | -4735.417% |
| Belite Bio, Inc | -87.27 Million USD | -95.271% |
| XOMA Corporation | -29 Million USD | -487.638% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -141.05% |
| Bionomics Limited | 227 Million USD | 175.069% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -46.553% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6627.793% |
| uniQure N.V. | -102.95 Million USD | -65.53% |
| Cassava Sciences, Inc. | -121.13 Million USD | -40.681% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3991.176% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 516.144% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1324.755% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -5407.563% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 160868.868% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -5154.857% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2013.7% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2197.937% |
| Altimmune, Inc. | -134.48 Million USD | -26.715% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 186.04% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -6627.793% |
| Compugen Ltd. | -12.9 Million USD | -1220.637% |
| Peak Bio, Inc. | 10.34 Million USD | 1748.089% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -60117.314% |
| Benitec Biopharma Inc. | -50.58 Million USD | -236.908% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -63.33% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 967.473% |
| Zura Bio Limited | -99.8 Million USD | -70.746% |
| PolyPid Ltd. | 6.17 Million USD | 2861.994% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 329.918% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 967.473% |
| Instil Bio, Inc. | 75.35 Million USD | 326.141% |
| argenx SE | -2.02 Billion USD | 91.6% |
| Immunome, Inc. | -97.02 Million USD | -75.633% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -657.568% |
| Verona Pharma plc | -220.44 Million USD | 22.694% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -137.535% |
| Shattuck Labs, Inc. | -121.42 Million USD | -40.347% |
| CervoMed Inc. | -7.79 Million USD | -2086.813% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 8.132% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -3796.981% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -29.357% |
| Moolec Science SA | 117.61 Thousand USD | 144991.001% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -7348.283% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1171.902% |
| AnaptysBio, Inc. | -18.15 Million USD | -838.874% |
| Design Therapeutics, Inc. | -18.15 Million USD | -838.926% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -142.132% |
| NeurAxis, Inc. | 145.7 Thousand USD | 117062.938% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1617.228% |
| Lumos Pharma, Inc. | -28.49 Million USD | -498.094% |
| Achilles Therapeutics plc | -126.92 Million USD | -34.265% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -137.535% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -25888.593% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -720.335% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 11787.254% |
| Nutriband Inc. | -251.65 Thousand USD | -67617.171% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1193.865% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2190.524% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 150.093% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 817.99% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 61.916% |
| Palisade Bio, Inc. | -12.06 Million USD | -1312.708% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -21.455% |
| Beam Therapeutics Inc. | -262.72 Million USD | 35.135% |
| Neurogene Inc. | -131.95 Million USD | -29.146% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 881.147% |
| AEON Biopharma, Inc. | -4.88 Million USD | -3392.111% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 54.82% |
| Sesen Bio, Inc. | -112.55 Million USD | -51.409% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -70.654% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -7158.519% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -336.67% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -104.624% |
| Athira Pharma, Inc. | -88.99 Million USD | -91.48% |
| Vaccinex, Inc. | -1.28 Million USD | -13130.978% |
| HCW Biologics Inc. | 2.85 Million USD | 6065.5% |
| XOMA Corporation | -29 Million USD | -487.638% |
| Nektar Therapeutics | 210.24 Million USD | 181.057% |
| Arvinas, Inc. | -313.8 Million USD | 45.693% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 10600.712% |
| Merus N.V. | -192.88 Million USD | 11.649% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 384.096% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -2356.255% |
| Rezolute, Inc. | -68.16 Million USD | -149.993% |
| Clene Inc. | 3.34 Million USD | 5202.246% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1192.295% |
| BeyondSpring Inc. | -13.75 Million USD | -1138.931% |
| Synlogic, Inc. | -6.68 Million USD | -2449.215% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 15127.778% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1915.553% |
| Peak Bio, Inc. | 10.34 Million USD | 1748.089% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -106.764% |
| Krystal Biotech, Inc. | -350.23 Million USD | 51.343% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 237.293% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -0.84% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -5297.758% |
| MannKind Corporation | 143.89 Million USD | 218.427% |
| Ikena Oncology, Inc. | -109.15 Million USD | -56.121% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2150.892% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -414.849% |
| Gossamer Bio, Inc. | 180.35 Million USD | 194.489% |
| CohBar, Inc. | -5.93 Million USD | -2773.423% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -472.862% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 3832.26% |
| Legend Biotech Corporation | -949.39 Million USD | 82.05% |
| Mural Oncology plc | -255.84 Million USD | 33.391% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 628.993% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -3517.66% |
| Disc Medicine, Inc. | -358.28 Million USD | 52.435% |
| Champions Oncology, Inc. | 4.81 Million USD | 3641.459% |
| REGENXBIO Inc. | 54.76 Million USD | 411.158% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -63273.211% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -12.84% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1790.977% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -111.215% |
| Vaxart, Inc. | -8.24 Million USD | -1967.892% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -239.608% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -34.01% |
| Cellectis S.A. | -43.85 Million USD | -288.587% |
| Longeveron Inc. | -2.9 Million USD | -5760.213% |
| Repare Therapeutics Inc. | -107.85 Million USD | -57.999% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 117.598% |
| Inozyme Pharma, Inc. | 12 Million USD | 1519.652% |
| Revolution Medicines, Inc. | -608.2 Million USD | 71.981% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -13754.878% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 35.721% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -13.555% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -989.123% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -22929.054% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.218% |
| Denali Therapeutics Inc. | -74.86 Million USD | -127.63% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1321.108% |
| Veru Inc. | 4.77 Million USD | 3665.19% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1415.339% |
| Cingulate Inc. | 3.08 Million USD | 5628.139% |
| Passage Bio, Inc. | 4.58 Million USD | 3816.794% |
| Context Therapeutics Inc. | -14.44 Million USD | -1079.357% |
| Exicure, Inc. | 5.84 Million USD | 3013.575% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 26.027% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -330.667% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1186.068% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -189.718% |
| Nuvalent, Inc. | -335.38 Million USD | 49.189% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 9925.922% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -128.8% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1816.929% |
| OmniAb, Inc. | 9.2 Million USD | 1951.733% |
| Anew Medical, Inc. | 1.43 Million USD | 11996.626% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1140.273% |
| Lipocine Inc. | -4.75 Million USD | -3484.219% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -55.165% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1218.869% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -236.396% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 784.618% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -2435.56% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -158.883% |
| Ocugen, Inc. | -32.52 Million USD | -424.015% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -99.141% |
| Q32 Bio Inc. | -37.94 Million USD | -349.075% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -27036.146% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1159.627% |
| Equillium, Inc. | -22.39 Million USD | -661.053% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -566.517% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -422.317% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -68639.286% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 227.136% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 5428.799% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 51986.031% |
| Dominari Holdings Inc. | 195 Thousand USD | 87492.308% |
| Edesa Biotech, Inc. | -5.26 Million USD | -3135.578% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1811.125% |
| Bio-Techne Corporation | 267.74 Million USD | 163.648% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -951.36% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -44.305% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1928.026% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1247.048% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 30.477% |
| Nkarta, Inc. | 57.29 Million USD | 397.414% |
| BioCardia, Inc. | 212 Thousand USD | 80484.434% |
| Iterum Therapeutics plc | 13.43 Million USD | 1368.157% |